You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 11, March 18, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in JAMA
 Topic Collections
 •Nutritional and Metabolic Disorders
 •Malabsorption Syndromes
 •Quality of Care
 •Quality of Care, Other
 •Diagnosis
 •Gastroenterology
 •Gastrointestinal Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Testing for Celiac Disease in Patients With Symptoms of Irritable Bowel Syndrome—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: Our systematic review focused on the role of the history and physical examination in making a diagnosis of IBS. It was not intended to be a guideline on how to manage IBS, so the issue of testing for celiac disease was not addressed in detail. We agree, however, that testing for celiac disease, with tissue transglutaminase (tTG) or anti-endomysial antibodies (EMAs), followed by distal duodenal biopsy for those testing positive, is useful in individuals presenting with symptoms suggestive of IBS. In another systematic review and meta-analysis that examined the yield of testing for celiac disease in patients meeting diagnostic criteria for IBS, the pooled prevalence of positive tTG or EMA in 13 studies containing 2021 individuals with symptoms suggestive of IBS was 1.6%, and the pooled prevalence of biopsy-proven celiac disease in 7 studies containing 1464 patients meeting diagnostic criteria for IBS was 4.1%.1 The odds ratio for . . . [Full Text of this Article]

Alexander C. Ford, MD, MRCP
Gastroenterology Division
McMaster University Health Sciences Center
Hamilton, Ontario, Canada

Nicholas J. Talley, MD, PhD
Department of Medicine
Mayo Clinic Florida
Jacksonville

Paul Moayyedi, PhD, FRCP
Gastroenterology Division
McMaster University Health Sciences Center
Hamilton



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Will the History and Physical Examination Help Establish That Irritable Bowel Syndrome Is Causing This Patient's Lower Gastrointestinal Tract Symptoms?
Alexander C. Ford, Nicholas J. Talley, Sander J. O. Veldhuyzen van Zanten, Nimish B. Vakil, David L. Simel, and Paul Moayyedi
JAMA. 2008;300(15):1793-1805.
ABSTRACT | FULL TEXT  

RELATED LETTER

Testing for Celiac Disease in Patients With Symptoms of Irritable Bowel Syndrome
Weekitt Kittisupamongkol
JAMA. 2009;301(11):1126.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.